IMDX: Prakiraan rega marang bathi imdxinc.com

Efficient express delivery of biomaterials guarantees the diagnostic accuracy of Insight Molecular Diagnostics (IMDX), which clearly demonstrates the company's expected price-to-earnings ratio. Strong pricing power is based on unique oncology tests, while the 0.00 indicator expresses the state of the metric. Currently, the business is launching systems into the market, meaning low sales are temporarily limiting the effect of operating leverage.

Kapitalisasi marang proyeksi bathi: Insight Molecular Diagnostics (IMDX) kanggo 19.06.2025 - 11.11.2026

Rincian analitis lan laporan data perusahaan Insight Molecular (IMDX)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Insight Molecular Diagnostics|IMDX - Bagan rega target

- informasi kapitalisasi pasar:

Biji pasar Insight Molecular Diagnostics, Inc.|IMDX - Total Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Insight Molecular Diagnostics|IMDX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku imdxinc.com|IMDX - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas Insight Molecular Diagnostics|IMDX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Insight Molecular Diagnostics|IMDX - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Insight Molecular Diagnostics, Inc.|IMDX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Insight Molecular Diagnostics|Rasio cepet imdxinc.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

IMDX - Asil keuangan resik|Proyeksi bathi mangsa ngarep Insight Molecular Diagnostics|IMDX - Rasio kapitalisasi marang bathi resik|Pangali Forward P/E Insight Molecular Diagnostics|IMDX - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Insight Molecular Diagnostics, Inc.|IMDX - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Insight Molecular Diagnostics|IMDX - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan imdxinc.com|IMDX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics

Analisis dhasar perusahaan:IMDX Insight Molecular Diagnostics Inc

Insight Molecular Diagnostics operates in the high-tech diagnostics sector, where the company's forward 12-month P/E reflects the ratio of current market value to projected net income. For an issuer with a high R&D cash burn, this chart allows for an assessment of the premium paid for future success in platform commercialization and insurance reimbursements, determining the degree of speculation in the current business valuation.

Karo sapa Insight Molecular Diagnostics saingan

Rega marang bathi mangsa ngarep Agilent (A)|Rega marang bathi mangsa ngarep DGX (Quest Diagnostics Inc.)|Illumina Corp - Prakiraan rega marang bathi|Exact Sciences Inc. (EXAS) - Rasio prakiraan rega marang bathi|RVTY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi bio-rad.com BIO|NNNN: Pangali Forward P/E|SHC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep QuidelOrtho Corp|OPKO Health Corp. (OPK) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E CDNA|Kapitalisasi marang proyeksi bathi maravai.com|Rega marang bathi mangsa ngarep Fulgent Genetics FLGT|LAB: Rasio rega marang bathi mangsa ngarep|CTKB - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi OraSure Corp OSUR|XGN: Pangali Forward P/E|MDXH - Kapitalisasi marang proyeksi bathi|LUCD (Lucid Diagnostics) - Pangali Forward P/E|PRE - Pangali forward rega marang bathi|Pangali Forward P/E TRIB|PRPH (ProPhase Labs Corp) - Pangali mangsa ngarep rega marang bathi|Ainos, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep CODX (codiagnostics.com)|HSCS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi BMRA (Biomerica Inc.)|cardiodiagnosticsinc.com (CDIO) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Onconetix Corporation|Rega marang bathi mangsa ngarep Virax Biolabs Group|Rasio prakiraan rega marang bathi bluejaydx.com BJDX|Rega marang bathi mangsa ngarep Aspira Women's Health Inc. (AWH)|Rega marang bathi mangsa ngarep AXDX (Accelerate Diagnostics Inc.)|Pangali Forward P/E CNTG (CENTOGENE N.V.)|Enzo Biochem Inc. (ENZ) - Rasio prakiraan rega marang bathi|Fresh2 - Pangali Forward P/E|Genetic Technologies (GENE) - Prakiraan rega marang bathi|ME (23andMe) - Prakiraan rega marang bathi|Psychemedics Corp. (PMD) - Pangali Forward P/E